Erste Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20,300
Closed -$2.33M 515
2020
Q4
$2.33M Sell
20,300
-1,800
-8% -$202K 0.06% 247
2020
Q3
$2.16M Hold
22,100
0.07% 236
2020
Q2
$2.69M Hold
22,100
0.11% 194
2020
Q1
$1.88M Sell
22,100
-2,400
-10% -$254K 0.11% 191
2019
Q4
$2.46M Hold
24,500
0.11% 185
2019
Q3
$2.85M Hold
24,500
0.15% 145
2019
Q2
$4.17M Buy
24,500
+7,000
+40% +$1.21M 0.22% 116
2019
Q1
$2.88M Hold
17,500
0.16% 137
2018
Q4
$1.65M Buy
+17,500
New +$2.3M 0.11% 178

Other funds holding GWPH

Erste Asset Management's GWPH Position: Q1 2021 in Review

Erste Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 20,300 shares — an estimated $2.33M sold.

Erste Asset Management first reported a position in GWPH in Q4 2018 and held it in 9 quarters. The position peaked at $4.17M in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Erste Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Erste Asset Management sold 20,300 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $2.33M.
  • Erste Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 9 quarters.
  • Erste Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.17M in Q2 2019.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Erste Asset Management's 13F filing for Q1 2021, filed 25 Nov 2024.